2-1648959-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_012293.3(PXDN):c.2821G>A(p.Val941Met) variant causes a missense change. The variant allele was found at a frequency of 0.00404 in 1,607,360 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0035 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 18 hom. )
Consequence
PXDN
NM_012293.3 missense
NM_012293.3 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 5.91
Publications
3 publications found
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
PXDN Gene-Disease associations (from GenCC):
- anterior segment dysgenesis 7Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009365916).
BP6
Variant 2-1648959-C-T is Benign according to our data. Variant chr2-1648959-C-T is described in ClinVar as Benign. ClinVar VariationId is 471913.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00347 (528/152146) while in subpopulation NFE AF = 0.00505 (343/67980). AF 95% confidence interval is 0.00461. There are 3 homozygotes in GnomAd4. There are 260 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PXDN | NM_012293.3 | c.2821G>A | p.Val941Met | missense_variant | Exon 17 of 23 | ENST00000252804.9 | NP_036425.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00347 AC: 528AN: 152026Hom.: 3 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
528
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00352 AC: 829AN: 235778 AF XY: 0.00349 show subpopulations
GnomAD2 exomes
AF:
AC:
829
AN:
235778
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00410 AC: 5966AN: 1455214Hom.: 18 Cov.: 70 AF XY: 0.00389 AC XY: 2816AN XY: 723238 show subpopulations
GnomAD4 exome
AF:
AC:
5966
AN:
1455214
Hom.:
Cov.:
70
AF XY:
AC XY:
2816
AN XY:
723238
show subpopulations
African (AFR)
AF:
AC:
30
AN:
33354
American (AMR)
AF:
AC:
23
AN:
44500
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
25958
East Asian (EAS)
AF:
AC:
0
AN:
39568
South Asian (SAS)
AF:
AC:
90
AN:
85968
European-Finnish (FIN)
AF:
AC:
569
AN:
50998
Middle Eastern (MID)
AF:
AC:
7
AN:
5742
European-Non Finnish (NFE)
AF:
AC:
5096
AN:
1109080
Other (OTH)
AF:
AC:
150
AN:
60046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
420
840
1261
1681
2101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00347 AC: 528AN: 152146Hom.: 3 Cov.: 33 AF XY: 0.00350 AC XY: 260AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
528
AN:
152146
Hom.:
Cov.:
33
AF XY:
AC XY:
260
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
31
AN:
41522
American (AMR)
AF:
AC:
13
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5132
South Asian (SAS)
AF:
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
AC:
140
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
343
AN:
67980
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
22
ALSPAC
AF:
AC:
17
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
40
ExAC
AF:
AC:
425
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Anterior segment dysgenesis 7 Benign:1
Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.